Seattle Genetics, Inc. (SGEN) Social Stream



Seattle Genetics, Inc. (SGEN): $139.20

-1.35 (-0.96%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SGEN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

SEAGEN INC (SGEN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SGEN.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-12 14 $210 $153 $182.846 $140.55 30.09%
2022-01-18 13 $210 $153 $182.615 $140.55 29.93%
2022-01-21 14 $210 $153 $182.615 $140.55 29.93%
2022-01-31 14 $210 $153 $182.384 $140.55 29.76%
2022-02-07 13 $210 $153 $182.384 $140.55 29.76%
2022-02-09 13 $210 $153 $180.769 $140.55 28.62%
2022-02-11 13 $198 $150 $168.25 $140.55 19.71%
2022-03-24 12 $195 $145 $162.5 $140.55 15.62%
2022-04-22 11 $195 $145 $162.75 $140.55 15.8%
2022-05-02 12 $195 $145 $162.75 $140.55 15.8%
2022-05-16 12 $195 $145 $162.583 $140.55 15.68%
2022-05-23 11 $195 $145 $163.454 $140.55 16.3%
2022-06-14 11 $195 $145 $163.818 $140.55 16.55%
2022-06-21 11 $208 $145 $170.909 $140.55 21.6%
2022-07-27 14 $220 $145 $176.571 $140.55 25.63%
2022-07-29 15 $220 $145 $179.333 $140.55 27.59%
2022-08-01 15 $220 $150 $183.285 $140.55 30.41%
2022-08-13 15 $220 $150 $184 $140.55 30.91%
2022-08-15 16 $220 $150 $183.533 $140.55 30.58%
2022-08-16 16 $220 $150 $184.133 $140.55 31.01%
2022-09-17 16 $220 $150 $184.666 $140.55 31.39%

The Trend in the Analyst Price Target


SGEN's average price target has moved up $21.36 over the prior 28 months.

Over the past 45 weeks, SGEN's average upside potential has been 18.7%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-23 14 210 153 182.846 173.82 5.19%
2021-12-27 14 210 153 182.846 157.67 15.97%
2022-01-12 14 210 153 182.846 141.03 29.65%
2022-02-09 13 210 153 180.769 141.41 27.83%
2022-02-11 13 195 145 162.500 125.37 29.62%

SGEN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.84 7 4 5 0 0 16

The Trend in the Broker Recommendations


Over the past 29 months, SGEN's average broker recommendation rating worsened by 0.04.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • SGEN has a higher average analyst price target than 2136.24% of Pharmaceutical Products stocks.
  • In terms of how SEAGEN INC fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is higher than 2040.07% of that group.
  • SEAGEN INC's upside potential (average analyst target price relative to current price) is higher than 286.19% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, SEAGEN INC's variance in analysts' estimates is lower than -423.42% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to SEAGEN INC are RGEN, QGEN, and NVAX.

Is SGEN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7017 seconds.